Reply to the Commentary on "An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant"

Anaesthesiol Intensive Ther. 2023;55(3):241-242. doi: 10.5114/ait.2023.130640.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anesthetics*
  • Humans
  • Neostigmine / therapeutic use
  • Neuromuscular Blockade*
  • Neuromuscular Diseases*
  • Sugammadex

Substances

  • Neostigmine
  • Sugammadex
  • Anesthetics